EROWID: Albert Hofmann passed away at his home at 9am on Tuesday Apr 29, 2008 of a heart attack at the age of 102. He will be missed. Albert Hofmann was born in Baden, Switzerland in 1906. He graduated from the University of Zürich with a degree in chemistry in 1929 and went to work for Sandoz Pharmaceutical in Basel, Switzerland. With the laboratory goal of working towards isolation of the active principles of known medicinal plants, Hofmann worked with Mediterranean squill (Scilla
maritima) for several years, before moving on to the study of Claviceps purpurea (ergot) and ergot alkaloids.Over the next few years, he worked his way through the lysergic acid derivatives, eventually synthesizing LSD-25 for the first time in 1938. After minimal testing, LSD-25 was set aside as he continued with other derivatives. Four years later, on April 16, 1943, he re-synthesized LSD-25 because he felt he might have missed something the first time around. That day, he became the first human to experience the effects of LSD after accidentally ingesting a minute amount. Three days later, on April 19, 1943, he decided to verify his results by intentionally ingesting 250 ug of LSD. This day has become known as “Bicycle Day” as Hofmann experienced an incredible bicycle ride on his way home from the lab.
In addition to his discovery of LSD, he was also the first to synthesize psilocybin (the active constituent of ‘magic mushrooms’) in 1958. Albert Hofmann, known as the ‘father of LSD’, continued to work at Sandoz until 1971 when he retired as Director of Research for the Department of Natural Products. He continued to write, lecture, and play a leading role as an elder in the psychedelic community until his death at the age of 102. MORE
WIKIPEDIA: Hofmann called LSD “medicine for the soul” and was frustrated by the worldwide prohibition that has pushed it underground. “It was used very successfully for 10 years in psychoanalysis,” he said, adding that the drug was hijacked by the youth movement of the 1960s and then unfairly demonized by the establishment that the movement opposed. He conceded that LSD can be dangerous in the wrong hands.[5] In December 2007, Swiss medical authorities permitted a psychotherapist to perform psychotherapeutical experiments with patients who suffer from terminal stage cancer and other deadly diseases. Although not yet started, these experiments will represent the first study of the therapeutic effects of LSD on humans in 35 years, as other studies have focused on the drug’s effects on consciousness and body. Hofmann supported the study, and continued to believe in the therapeutic benefits of LSD.[7] Hofmann was due to speak at the World Psychedelic Forum[6] from March 21 to March 24, 2008 but was forced to pull out due to poor health. MORE